# Dual bNAb Treatment in Children

> **NCT03707977** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** ART
- **BIOLOGICAL:** VRC01LS
- **BIOLOGICAL:** 10-1074

## Key facts

- **NCT ID:** NCT03707977
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-17
- **Primary completion:** 2021-12-03
- **Final completion:** 2021-12-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707977, "Dual bNAb Treatment in Children". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03707977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*